EU for Evibodies

By Kate McDonald
Monday, 09 February, 2009

Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.

Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.

Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.

They were given a US patent in 2007.

Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...

After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...

To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...

Content from other channels on our network

Six key pillars of frailty prevention and management

Protecting the people who protect us: PPE continuity during demand surge

WA steps in to ensure 'continuity' of operations at Mount Private Hospital

What healthcare boards need from risk leaders

Additional $22.9m in research grants for nation's biggest killer

A high-speed, real-time optical data connection for industrial applications

Redesigning for decarbonisation: the shift towards electrified hydraulic power

Chinese humanoid robot manufacturer opens mass production plant

A guide to a cost-effective SIS

NSW launches Local Jobs First Commission legislation

SA retirement village reduces energy costs using solar system

Battery-free sensors close to reality

How do we prepare for a hotter, more populated, Sydney?

Flux Marine Redefines Marine Propulsion Through Electrification

Australian industry won't hit net zero if organisations hoard their data